The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?
① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.
After failing to make a successful push for the BSE, Huanhe Eco-friendly Concept switched to the Hong Kong stock market and passed the hearing. The founder had previously "urgently" issued salaries exceeding 7 million.
① The controlling shareholders of the Eco-friendly Concept Holding are Zhou Yang, Zhao Mingzhu, and Chen Zhiyuan, who act in concert and jointly hold 95% of the shares through an employee stock ownership platform; ② The Eco-friendly Concept stated that the Ship environmental protection equipment and system Industry is highly fragmented and competitive.
china cssc Q3 net profit plummeted by 57%! Active institutional funds fled after the announcement of the merger of the two ships|interpretations
①China CSSC achieved a revenue of 20.152 billion yuan in Q3, a year-on-year increase of 5.35%; net income of 0.858 billion yuan, a year-on-year decrease of 57.26%; ②Compared to September 2 before the announcement of the merger of the two ships, by the end of September, shareholders of the company, including northbound funds, civil-military integration industry investment funds, and Citic Securities-Changfeng single asset management plan, have all reduced their positions.
Foreign public fund latest hold positions exposure! Fund managers are bullish on china's stock market valuation repair.
With the disclosure of the third quarter report, public funds under international asset management giants such as BlackRock and Fidelity have all their holdings exposed.
Unveil! With huge trading volume, which A-shares are institutions chasing after?
The heat of A shares is still continuing!
Long-serving senior executive of lepu medical technology resigns, can the second generation successor stop the decline in performance? | Express announcement
①Tonight, lepu medical technology announced the resignation of General Manager Zhang Zhibin and Deputy General Manager Zheng Guorui, with Chairman's daughter Pu Fei taking over as General Manager, who has a background of "sea turtle elite"; ②Starting from 2023, lepu medical technology's performance has declined for several consecutive quarters, with market cap dropping by a quarter compared to the peak period.